RxDoctor Payments Data

Emily Merkel, MD

MOHS-Micrographic Surgery · Nashville, TNNPI 1497286033

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.4% of the total across 81 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 15 manufacturers reported payments, led by AbbVie at 28.5% of the total. Reporting peaked in 2023 at $817 and has fallen 51.3% since, to $398 in 2025. That places this record below the midpoint for mohs-micrographic surgery clinicians in TN, where the typical reported total is $4,344.

$2,358in general payments, 2019–2025

Across 81 payments — averaging $29.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$671
  • Johnson & Johnson$281
  • Pfizer$277
  • Sanofi$248
  • UCB, Inc.$147
  • Regeneron Healthcare Solutions, Inc.$121
  • plus $612 from 9 others

What the payments were for

  • Food & beverage$2,34299%
  • Education$151%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,358 in reported general payments places this provider in the 40th percentile of 40 mohs-micrographic surgery providers in Tennessee.

See all mohs-micrographic surgery providers in Tennessee

Medicare billing

Part B allowed, 2024
$158,779
Medicare patients
319
Services billed
847

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab14$55,697
Clobetasol Propionate12$715
Ketoconazole35$667
Triamcinolone Acetonide23$262
Doxycycline Monohydrate16$229
Mupirocin35$205
Doxycycline Hyclate21$168

Paid to pharmacies, not to this prescriber.

Other mohs-micrographic surgery in Nashville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →